Table 2.

Deforming/erosive arthropathy and anti-CCP antibodies in SLE.

ReportSelectionAnti-CCP in Deforming/Erosive Arthropathy, %Anti-CCP in Nonerosive Arthropathy, %Deforming/Erosive Arthropathy in Anti-CCP, %
Mediwake18 2001Deformity or erosion13 (2/16)2 (1/50)67 (2/3)
Erosive 20 (2/10)
Nonerosive 0 (0/6)
Takasaki13 2004 (MCTD, 7/8 had SLE)RA criteria or anti-CCP44 (4/9)NA50 (4/8) deformity
63 (5/8) erosion
Amezcua-Guerra19 2006RA criteria57 (4/7)0100 (4/4)
Rothfield32 2007RA criteria?67 (2/3)NANA
Martinez20 2007Erosion80 (4/5)NANA
Chan21 2008Erosion50 (6/12)3 (2/59)88 (7/8)
Damian-Abrego22 2008Deformity (11/14 had erosion)7 (1/14)5 (1/20)90 (10/11)
RA criteria100 (9/9)
Kakumanu 2009American, deformity or erosion30 (6/20)16 (41/251)13 (6/47)
2009Japanese, deformity or erosion67 (4/6)NANA
  • NA: not applicable.